Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,665 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.
Narita T, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Shimoda J, Kawaguchi T, Ishidoya S, Mitsuzuka K, Arai Y, Ito A, Tsuchiya N, Habuchi T, Ohyama C. Narita T, et al. Among authors: kawaguchi t. Transl Androl Urol. 2021 Jan;10(1):417-425. doi: 10.21037/tau-20-966. Transl Androl Urol. 2021. PMID: 33532329 Free PMC article.
Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.
Okamoto T, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C. Okamoto T, et al. Among authors: kawaguchi t. World J Urol. 2019 Sep;37(9):1827-1835. doi: 10.1007/s00345-018-2590-2. Epub 2018 Dec 4. World J Urol. 2019. PMID: 30511214
Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer.
Hamano I, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C. Hamano I, et al. Among authors: kawaguchi t. World J Urol. 2019 Nov;37(11):2365-2373. doi: 10.1007/s00345-019-02664-3. Epub 2019 Feb 7. World J Urol. 2019. PMID: 30729312
Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
Narita S, Nomura K, Hatakeyama S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Ohyama C, Arai Y, Nagashima K, Habuchi T. Narita S, et al. Among authors: kawaguchi t. Cancer Med. 2019 Nov;8(15):6566-6577. doi: 10.1002/cam4.2502. Epub 2019 Sep 11. Cancer Med. 2019. PMID: 31508900 Free PMC article.
Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan.
Narita S, Hatakeyama S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Koizumi A, Mitsuzuka K, Tochigi T, Tsuchiya N, Ohyama C, Arai Y, Nomura K, Habuchi T. Narita S, et al. Among authors: kawaguchi t. Int J Clin Oncol. 2020 May;25(5):912-920. doi: 10.1007/s10147-019-01614-8. Epub 2020 Jan 9. Int J Clin Oncol. 2020. PMID: 31919691
Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Hamano I, Okamoto T, Mitsuzuka K, Ito A, Tsuchiya N, Arai Y, Habuchi T, Ohyama C. Hatakeyama S, et al. Among authors: kawaguchi t. Int J Urol. 2020 Jul;27(7):610-617. doi: 10.1111/iju.14258. Epub 2020 May 16. Int J Urol. 2020. PMID: 32418347
Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.
Okamoto T, Noro D, Hatakeyama S, Narita S, Mitsuzuka K, Sakurai T, Kawamura S, Hoshi S, Shimoda J, Tanaka T, Kawaguchi T, Ishidoya S, Ito A, Tsuchiya N, Habuchi T, Ohyama C. Okamoto T, et al. Among authors: kawaguchi t. BMC Cancer. 2021 May 25;21(1):605. doi: 10.1186/s12885-021-08206-8. BMC Cancer. 2021. PMID: 34034691 Free PMC article.
Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer.
Kodama H, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Narita T, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C. Kodama H, et al. Among authors: kawaguchi t. Clin Genitourin Cancer. 2019 Dec;17(6):e1091-e1098. doi: 10.1016/j.clgc.2019.05.029. Epub 2019 Sep 10. Clin Genitourin Cancer. 2019. PMID: 31575477
Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer.
Narita S, Nomura K, Hatakeyama S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Ohyama C, Arai Y, Nagashima K, Habuchi T. Narita S, et al. Among authors: kawaguchi t. Sci Rep. 2019 Aug 19;9(1):12071. doi: 10.1038/s41598-019-48600-8. Sci Rep. 2019. PMID: 31427687 Free PMC article.
The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study.
Okita K, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Ito A, Tsuchiya N, Arai Y, Habuchi T, Ohyama C. Okita K, et al. Among authors: kawaguchi t. Clin Genitourin Cancer. 2020 Apr;18(2):e103-e111. doi: 10.1016/j.clgc.2019.09.006. Epub 2019 Sep 27. Clin Genitourin Cancer. 2020. PMID: 31810867
2,665 results